<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>stomach sparing &#8211; Clinical Robotics</title>
	<atom:link href="https://clinicalrobotics.com/tag/stomach-sparing/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicalrobotics.com</link>
	<description></description>
	<lastBuildDate>Thu, 30 Apr 2026 10:49:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	

<image>
	<url>https://clinicalrobotics.com/wp-content/uploads/2018/01/cropped-logo-x-google-32x32.png</url>
	<title>stomach sparing &#8211; Clinical Robotics</title>
	<link>https://clinicalrobotics.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Robotic wedge resection for gastric GIST</title>
		<link>https://clinicalrobotics.com/robotic-wedge-resection-for-gastric-gist/</link>
		<pubDate>Sun, 16 Feb 2014 06:00:00 +0000</pubDate>
		<dc:creator><![CDATA[smth]]></dc:creator>
				<category><![CDATA[Upper GI]]></category>
		<category><![CDATA[Video Gallery]]></category>
		<category><![CDATA[edited video]]></category>
		<category><![CDATA[gastric GIST]]></category>
		<category><![CDATA[gastric resection]]></category>
		<category><![CDATA[Parisi]]></category>
		<category><![CDATA[stomach sparing]]></category>
		<category><![CDATA[Terni]]></category>

		<guid isPermaLink="false">http://www.clinicalrobotics.com/index.php/7907/robotic-wedge-resection-for-gastric-gist/</guid>
		<description><![CDATA[<p><img src="https://mediahttp.clinicalrobotics.com/thumbs/25v8uqgtbtwb7x3n.jpg">A. Parisi<br />
The stomach is the most common site for the development of gastrointestinal stromal tumours. The minimally invasive procedure is debated and must be evaluated based on the risk of breakage and fragmentation of the neoplasm. Actually, the use of the robotic system has become progressively common as an approach for benign and malignant stomach diseases.</p>
<p>A new post has been published on <a rel="nofollow" href="https://clinicalrobotics.com">Clinical Robotics</a>.</p>
]]></description>
				<content:encoded><![CDATA[<img src="https://mediahttp.clinicalrobotics.com/thumbs/25v8uqgtbtwb7x3n.jpg"><p>A. Parisi</p>
<p>The stomach is the most common site for the development of gastrointestinal stromal tumours. The minimally invasive procedure is debated and must be evaluated based on the risk of breakage and fragmentation of the neoplasm. Actually, the use of the robotic system has become progressively common as an approach for benign and malignant stomach diseases. The robotic system, in centres with expertise in minimally invasive surgery, may be an option that allows improving surgical accuracy and safety in patients with GISTs that require technical accuracy.</p>
<p>A new post has been published on <a rel="nofollow" href="https://clinicalrobotics.com">Clinical Robotics</a>.</p>
]]></content:encoded>
			</item>
	</channel>
</rss>
